Mpox Vaccine Campaign in Africa: Progress and Challenges

The Democratic Republic of Congo receives its first Mpox vaccine doses as the EU donates 175,420 doses to combat the outbreak, declared a public health emergency by the WHO. WHO Director-General Tedros urges more countries to contribute.

Information campaigns are launched, although the actual number of suspected cases surpasses 18,000. Rapid distribution plans aim to reach high-risk regions swiftly.

Challenges remain, including distribution hurdles and low vaccine acceptance rates, reminiscent of past Ebola outbreaks. Countries like the US and Indonesia step in with donations and support, while hopes rise for the new mRNA-1769 vaccine developed by Moderna and USAMRIID, showing promising results in trials against Mpox.

The urgency of the situation underscores the need for global cooperation and innovative solutions to contain and prevent the spread of the disease across Africa.